QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 genprex-to-present-positive-preclinical-data-at-2025-aacr-nci-erotc-international-conference-on-molecular-targets-and-cancer-therapeutics-in-boston

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on dev...

 genprex-implements-previously-disclosed-1-for-50-reverse-stock-split-reducing-outstanding-shares-to-1004326

As of 12:01 a.m. on October 21, 2025, Genprex, Inc., a Delaware corporation (the "Company"), effected the previously di...

 genprex-gnpx-shares-jump-41-after-hours-following-new-cancer-therapy-data

Genprex shares jumped 41% in after-hours trading following news of a key cancer therapy presentation and ongoing research colla...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION